Govt Job: For M.Pharm, MSc at PGIMER | Salary Rs. 72,600 pm

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Post : Senior Course Assistant

Project title : “Online Course in Basic Health Economics and Economic Evaluation for Health Technology Assessment.”

Department : Department of Community Medicine & School of Public Health, PGIMER, Chandigarh

Qualification
Essential :

Master’s degree in Public Health / Health Management / Hospital Administration / Pharmacy / MD Community Medicine with 1 year teaching or research experience.

Desirable :
Experience of writing project reports, publication in peer review journals.
Knowledge and skills of Decision Modelling.
Experience of undertaking economic evaluation studies.

Duration : Up to December.- 2023

Emolument s per months (in Rs.) : 72,600/-

How to Apply : Interested candidates should submit their curriculum vitae with supporting documents to Mr Anil Kumar, Room No-004 Department of Community Medicine and School of Public Health PGIMER, Chandigarh or may also apply through online mode by sending email to recruitment.htapgi@gmail.com by 12th May, at 12.00 PM 2022.

No application by any means will be received or entertained after last date. You will be informed in case there is any change in schedule/mode of recruitment process.

Date of Interview : 14th May 2022 at 09.00 AM.

Venue : Committee Room, Community Medicine and School of Public Health, PGIMER, Chandigarh.

Related Posts

  • Pharma
  • July 11, 2025
  • 87 views
India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

July:  India’s Glenmark Pharmaceuticals (GLEN.NS), opens new tab said on Thursday its innovation arm, Ichnos Glenmark Innovation (IGI), and AbbVie (ABBV.N), opens new tab have signed an exclusive licensing agreement…

  • Pharma
  • July 10, 2025
  • 146 views
Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

India stands tall as a pharmaceutical powerhouse, supplying 20% of the world’s generic medicines and nearly 62% of global vaccines. Yet, this success now faces a storm: US President Donald…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Novartis wins approval for first malaria drug for newborns and babies

Novartis wins approval for first malaria drug for newborns and babies